Digital Ulceration
NCT01377090 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 630
Last updated 2013-07-15
Summary
The CAP study is a multicenter, observational, clinical study in patients with systemic sclerosis. The study aims at determining the usefulness of nailfold videocapillaroscopy and patient-specific disease-related factors in predicting the occurrence of digital ulcers within a 6-month observation period. Patients with cutaneous forms of systemic sclerosis (limited or diffuse), with or without history of digital ulceration are eligible. The study will enroll 500 patients at 70 centers.
Conditions
- Systemic Sclerosis
- Digital Ulcers
Sponsors & Collaborators
-
Actelion
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2012-07-31
- Completion
- 2012-08-31
Countries
- Austria
- Belgium
- Czechia
- France
- Germany
- Greece
- Israel
- Italy
- Netherlands
- Norway
- Portugal
- Spain
- Switzerland
- Turkey (Türkiye)
- United Kingdom
Study Locations
More Related Trials
-
Dermoscopy in Primary Raynaud's Phenomenon
NCT04644523 ·Status: COMPLETED
-
Subcutaneous Injections of ASC to Heal Digital Ulcers in Patients With Scleroderma.
NCT04356755 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy of a Personalized Rehabilitation Program of Facial Involvement in Systemic Sclerosis
NCT05177380 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Calcinosis in Systemic Sclerosis
NCT03340194 ·Status: COMPLETED
-
Trichoscopy and Systemic Scleroderma
NCT04804930 ·Status: RECRUITING
-
Early Diagnosis of SSc in the General Rheumatology Clinic - Pilot
NCT06291142 ·Status: COMPLETED
-
Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis.
NCT01743612 ·Status: COMPLETED ·Phase: NA
-
Open-Label Study of Oral Treprostinil in Digital Ulcers
NCT00848107 ·Status: TERMINATED ·Phase: PHASE2
-
Co-designing Digital Ulcers Opportunities With Patients and Clinicians
NCT05785403 ·Status: UNKNOWN
-
Sildenafil for Treatment of Digital Ulcers in Patients With Systemic Sclerosis
NCT00624273 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Manifestations of Systemic Sclerosis
NCT02371005 ·Status: TERMINATED ·Phase: NA
-
Autologous Adipose Tissue in the Treatment of Systemic Sclerosis Digital Ulcers
NCT03406988 ·Status: UNKNOWN ·Phase: NA
-
Injection of Autologous Adipose-derived Stromal Vascular Fraction in the Finger of Systemic Sclerosis Patients
NCT03060551 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Stem Cell Factor, a Potential Biological Marker of Skin Involvement in Systemic Sclerosis?
NCT05482594 ·Status: UNKNOWN
-
Scleroderma: Functional Disability Between the Dominant and Contralateral Hand.
NCT05171114 ·Status: COMPLETED ·Phase: NA
-
Targeting the Mechanisms Underlying Cutaneous Neurofibroma Formation in NF1: A Clinical Translational Approach.
NCT02777775 ·Status: COMPLETED
-
Stimulatory Autoantibodies to the Platelet-Derived Growth Factor Receptor (PDGFR) in Patients With Systemic Sclerosis
NCT00667134 ·Status: COMPLETED
-
Metabolomic Analysis of Systemic Sclerosis
NCT02298777 ·Status: TERMINATED
-
Microvascular and Fibrosis Imaging Study
NCT01758250 ·Status: COMPLETED
-
Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma
NCT00077584 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of the Subcutaneous Reinjection of Human Autologous Adipose-derived Stromal Vascular Fraction (Celution® System) in the Hands of Patients Suffering From Systemic Sclerosis
NCT01813279 ·Status: COMPLETED ·Phase: NA
-
Platelet Gel in Systemic Sclerosis
NCT00463125 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Evaluating Gut Imaging and Stool Biomarkers in Patients With Scleroderma-associated Gastrointestinal Disease
NCT04630782 ·Status: UNKNOWN
-
Implementation of a Biological Sample Collection in Systemic Sclerosis Patients
NCT04986514 ·Status: WITHDRAWN
-
Assessment of the Prevalence of Olfactory Disorders in Systemic Scleroderma
NCT04178616 ·Status: TERMINATED ·Phase: NA